Cargando…
Emerging Role of Epigenetic Alterations as Biomarkers and Novel Targets for Treatments in Pancreatic Ductal Adenocarcinoma
SIMPLE SUMMARY: Epigenetic alterations cause changes in gene expression without affecting the DNA sequence and are found to affect several molecular pathways in pancreatic tumors. Such changes are reversible, making them potential drug targets. Furthermore, epigenetic alterations occur early in the...
Autores principales: | Roalsø, Marcus T. T., Hald, Øyvind H., Alexeeva, Marina, Søreide, Kjetil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833770/ https://www.ncbi.nlm.nih.gov/pubmed/35158814 http://dx.doi.org/10.3390/cancers14030546 |
Ejemplares similares
-
The prognostic relevance of examined lymph nodes for accurate staging of resected pancreatic adenocarcinoma
por: Zaharia, Claudia, et al.
Publicado: (2022) -
Is There a Trojan Horse to Aggressive Pancreatic Cancer Biology? A Review of the Trypsin-PAR2 Axis to Proliferation, Early Invasion, and Metastasis
por: Søreide, Kjetil, et al.
Publicado: (2020) -
Early Diagnosis of Pancreatic Cancer: Clinical Premonitions, Timely Precursor Detection and Increased Curative-Intent Surgery
por: Søreide, Kjetil, et al.
Publicado: (2023) -
Combined Analysis of the Aberrant Epigenetic Alteration of Pancreatic Ductal Adenocarcinoma
por: Xu, Rui, et al.
Publicado: (2019) -
Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
por: Qian, Yunzhen, et al.
Publicado: (2020)